国际肿瘤学杂志››2016,Vol. 43››Issue (2): 110-.
王小利, 常永超, 刘刚
出版日期:
2016-02-08发布日期:
2015-12-28WANG Xiao-Li, CHANG Yong-Chao, LIU Gang
Online:
2016-02-08Published:
2015-12-28摘要:超过50%的微小RNA(miRNA)定位于肿瘤相关的基因组扩增区域或脆性位点,可具有癌基因或抑癌基因的功能。近年来研究显示,在人类胃癌、肺癌、卵巢癌等恶性肿瘤中miR449表达降低,被认为是一个抑癌miRNA。miR449表达异常可能与肿瘤的发生和发展过程密切相关,研究其功能及调控机制,可为肿瘤诊断、治疗和预后判断提供重要线索。
王小利, 常永超, 刘刚. 微小RNA-449在肿瘤中的作用及其调控机制[J]. 国际肿瘤学杂志, 2016, 43(2): 110-.
WANG Xiao-Li, CHANG Yong-Chao, LIU Gang. Role and regulatory mechanism of microRNA449 in cancer[J]. Journal of International Oncology, 2016, 43(2): 110-.
[1] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin4 encodes small RNAs with antisense complementarity to lin14[J]. Cell, 1993, 75(5): 843854. [2] Noonan EJ, Place RF, Pookot D, et al. miR449a targets HDAC1 and induces growth arrest in prostate cancer[J]. Oncogene, 2009, 28(14): 17141724. DOI:10.1038/onc.2009.19. [3] Lizé M, Pilarski S, Dobbelstein M. E2F1inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis[J]. Cell Death Differ, 2010, 17(3): 452458. DOI:10.1038/cdd.2009.188. [4] Feng M, Yu Q. miR449 regulates CDKRbE2F1 through an autoregulatory feedback circuit[J]. Cell Cycle, 2010, 9(2): 213214. [5] Noonan EJ, Place RF, Basak S, et al. miR449a causes rbdependent cell cycle arrest and senescence in prostate cancer cells[J]. Oncotarget, 2010, 1(5): 349358. [6] Bou Kheir T, FutomaKazmierczak E, Jacobsen A, et al. miR449 inhibits cell proliferation and is downregulated in gastric cancer[J]. Mol Cancer, 2011, 10: 29. DOI:10.1186/147645981029. [7] Luo W, Huang B, Li Z, et al. MicroRNA449a is downregulated in nonsmall cell lung cancer and inhibits migration and invasion by targeting cMet[J]. PLoS One, 2013, 8(5): e64759. DOI:10.1371/journal.pone.0064759. [8] Jeon HS, Lee SY, Lee EJ, et al. Combining microRNA449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer[J]. Lung Cancer, 2012, 76(2): 171176. DOI:10.1016/j.lungcan.2011.10.012. [9] Ma LP, Li N, He XJ, et al. miR449b and miR34c on inducing downregulation of cell cyclerelated proteins and cycle arrests in SKOV3ipl cell, an ovarian cancer cell line[J]. Beijing Da Xue Xue Bao, 2011, 43(1): 129133. [10] Lizé M, Klimke A, Dobbelstein M. MicroRNA449 in cell fate determination[J]. Cell Cycle, 2011, 10(17): 28742882. [11] Tsujiura M, Ichikawa D, Komatsu S, et al. Circulating microRNAs in plasma of patients with gastric cancers[J]. Br J Cancer, 2010, 102(7): 11741179. DOI:10.1038/sj.bjc.6605608. [12] Lizé M, Herr C, Klimke A, et al. MicroRNA449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia[J]. Cell Cycle, 2010, 9(22): 45794583. [13] Marcet B, Chevalier B, Luxardi G, et al. Control of vertebrate multiciliogenesis by miR449 through direct repression of the Delta/Notch pathway[J]. Nat Cell Biol, 2011, 13(6): 693699. DOI:10.1038/ncb2241. [14] Ito T, Udaka N, Yazawa T, et al. Basic helixloophelix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium[J]. Development, 2000, 127(18): 39133921. [15] Taichman DB, Loomes KM, Schachtner SK, et al. Notch1 and jagged1 expression by the developing pulmonary vasculature[J]. Dev Dyn, 2002, 225(2): 166175. DOI:10.1002/dvdy.10146. [16] Hoesel B, Bhujabal Z, Przemeck GK, et al. Combination of in silico and in situ hybridisation approaches to identify potential Dll1 associated miRNAs during mouse embryogenesis[J]. Gene Expr Patterns, 2010, 10(6): 265273. DOI:10.1016/j.gep.2010.06.002. [17] Liu YJ, Lin YF, Chen YF, et al. MicroRNA449a enhances radiosensitivity in CL10 lung adenocarcinoma cells[J]. PLoS One, 2013, 8(4): e62383. DOI:10.1371/journal.pone.0062383. [18] Karst AM, Drapkin R. Ovarian cancer pathogenesis: a model in evolution[J]. J Oncol, 2010: 932371. DOI:10.1155/2010/932371. [19] Chen H, Lin YW, Mao YQ, et al. MicroRNA449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins[J]. Cancer Lett, 2012, 320(1): 4047. DOI:10.1016/j.canlet.2012.01.027. [20] Buurman R, Gürlevik E, Schffer V, et al. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA449 in hepatocellular carcinoma cells[J]. Gastroenterology, 2012, 143(3): 811820. DOI:10.1053/j.gastro.2012.05.033. [21] Zhang H, Feng Z, Huang R, et al. MicroRNA449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1[J]. Int J Oncol, 2014, 45(5): 21432152. DOI:10.3892/ijo.2014.2596. [22] Jang SG, Yoo CW, Park SY, et al. Low expression of miR449 in gynecologic clear cell carcinoma[J]. Int J Gynecol Cancer, 2014, 24(9): 15581563. DOI:10.1097/IGC.0000000000000267. [23] Jukic DM, Rao UN, Kelly L, et al. Microrna profiling analysis of differences between the melanoma of young adults and older adults[J]. J Transl Med, 2010, 8: 27. DOI:10.1186/14795876827. |
[1] | 刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325. |
[2] | 杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337. |
[3] | 袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343. |
[4] | 陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349. |
[5] | 郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353. |
[6] | 张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358. |
[7] | 许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363. |
[8] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
[9] | 张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375. |
[10] | 高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
[11] | 王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384. |
[12] | 刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273. |
[13] | 杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279. |
[14] | 王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285. |
[15] | 张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||